Fertility drugs, reproductive strategies and ovarian cancer risk

19Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer. © 2014 Tomao et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Tomao, F., Lo Russo, G., Spinelli, G. P., Stati, V., Prete, A. A., Prinzi, N., … Tomao, S. (2014, May 8). Fertility drugs, reproductive strategies and ovarian cancer risk. Journal of Ovarian Research. BioMed Central Ltd. https://doi.org/10.1186/1757-2215-7-51

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free